Thymidine kinase-mediated shut down of bone morphogenetic protein-4 expression allows regulated bone production

Barbara Lombardo, Teresa Rocco, Maria T. Esposito, Bruno Cantilena, Sara Gargiulo, Adelaide Greco, Donatella Montanaro, Arturo Brunetti, Lucio Pastore

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Bone morphogenetic Proteins (BMPs) are growth factors also involved in ossification and chondrogenesis that have generated interest for their efficiency in inducing bone neo-synthesis. BMPs expression in engineered cells has been successful in stimulating osteoblastic differentiation and ectopic and orthotopic bone formation in vivo. We have previously shown that an adenoviral vector expressing bone morphogenetic protein type-4 (BMP-4) is able to efficiently drive bone formation in a rabbit model of discontinuous bone lesions. However, unregulated secretion of BMPs has also been implicated in bone overproduction and exostosis. We have constructed a replication-defective first generation adenoviral (FG-Ad) vector containing a cassette for the expression of BMP-4 associated with the Herpes Simplex virus thymidine kinase (TK) gene (FG-B4TK) in order to shut down BMP-4 expression and, therefore, regulate bone production. TK expression does not interfere with BMP-4 ability to induce ectopic bone formation in athymic nude mice. Administration of ganciclovir blocks ectopic bone production in quadriceps muscle transduced with the FG-B4TK with no effect on the contralateral muscle transduced with a vector expressing only BMP-4. Histological findings confirmed the pro-apoptotic activity of TK and the reduction of mineralized areas in the quadriceps transduced with FG-B4TK in mice treated with ganciclovir. We have generated a system to block BMP-4 secretion by inducing apoptosis in transduced cells therefore blocking unwanted bone formation. This system is an additional tool to generate regulated amount of bone in discontinuous bone lesions and can be easily coupled with biomaterials capable of recruiting cells and generating a local bioreactor.

Original languageEnglish
Pages (from-to)202-210
Number of pages9
JournalCurrent Gene Therapy
Volume13
Issue number3
DOIs
Publication statusPublished - 2013

Fingerprint

Bone Morphogenetic Protein 4
Thymidine Kinase
Osteogenesis
Bone and Bones
Bone Morphogenetic Proteins
Ganciclovir
Nude Mice
Exostoses
Chondrogenesis
Quadriceps Muscle
Biocompatible Materials
Bioreactors
Simplexvirus
Intercellular Signaling Peptides and Proteins
Apoptosis
Rabbits
Muscles

Keywords

  • Bone production regulation
  • Fg-B4
  • Fg-B4TK

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Molecular Medicine
  • Genetics(clinical)
  • Drug Discovery

Cite this

Lombardo, B., Rocco, T., Esposito, M. T., Cantilena, B., Gargiulo, S., Greco, A., ... Pastore, L. (2013). Thymidine kinase-mediated shut down of bone morphogenetic protein-4 expression allows regulated bone production. Current Gene Therapy, 13(3), 202-210. https://doi.org/10.2174/1566523211313030005

Thymidine kinase-mediated shut down of bone morphogenetic protein-4 expression allows regulated bone production. / Lombardo, Barbara; Rocco, Teresa; Esposito, Maria T.; Cantilena, Bruno; Gargiulo, Sara; Greco, Adelaide; Montanaro, Donatella; Brunetti, Arturo; Pastore, Lucio.

In: Current Gene Therapy, Vol. 13, No. 3, 2013, p. 202-210.

Research output: Contribution to journalArticle

Lombardo, B, Rocco, T, Esposito, MT, Cantilena, B, Gargiulo, S, Greco, A, Montanaro, D, Brunetti, A & Pastore, L 2013, 'Thymidine kinase-mediated shut down of bone morphogenetic protein-4 expression allows regulated bone production', Current Gene Therapy, vol. 13, no. 3, pp. 202-210. https://doi.org/10.2174/1566523211313030005
Lombardo, Barbara ; Rocco, Teresa ; Esposito, Maria T. ; Cantilena, Bruno ; Gargiulo, Sara ; Greco, Adelaide ; Montanaro, Donatella ; Brunetti, Arturo ; Pastore, Lucio. / Thymidine kinase-mediated shut down of bone morphogenetic protein-4 expression allows regulated bone production. In: Current Gene Therapy. 2013 ; Vol. 13, No. 3. pp. 202-210.
@article{4ae4276976a14f4f8122f2e7c61bd07b,
title = "Thymidine kinase-mediated shut down of bone morphogenetic protein-4 expression allows regulated bone production",
abstract = "Bone morphogenetic Proteins (BMPs) are growth factors also involved in ossification and chondrogenesis that have generated interest for their efficiency in inducing bone neo-synthesis. BMPs expression in engineered cells has been successful in stimulating osteoblastic differentiation and ectopic and orthotopic bone formation in vivo. We have previously shown that an adenoviral vector expressing bone morphogenetic protein type-4 (BMP-4) is able to efficiently drive bone formation in a rabbit model of discontinuous bone lesions. However, unregulated secretion of BMPs has also been implicated in bone overproduction and exostosis. We have constructed a replication-defective first generation adenoviral (FG-Ad) vector containing a cassette for the expression of BMP-4 associated with the Herpes Simplex virus thymidine kinase (TK) gene (FG-B4TK) in order to shut down BMP-4 expression and, therefore, regulate bone production. TK expression does not interfere with BMP-4 ability to induce ectopic bone formation in athymic nude mice. Administration of ganciclovir blocks ectopic bone production in quadriceps muscle transduced with the FG-B4TK with no effect on the contralateral muscle transduced with a vector expressing only BMP-4. Histological findings confirmed the pro-apoptotic activity of TK and the reduction of mineralized areas in the quadriceps transduced with FG-B4TK in mice treated with ganciclovir. We have generated a system to block BMP-4 secretion by inducing apoptosis in transduced cells therefore blocking unwanted bone formation. This system is an additional tool to generate regulated amount of bone in discontinuous bone lesions and can be easily coupled with biomaterials capable of recruiting cells and generating a local bioreactor.",
keywords = "Bone production regulation, Fg-B4, Fg-B4TK",
author = "Barbara Lombardo and Teresa Rocco and Esposito, {Maria T.} and Bruno Cantilena and Sara Gargiulo and Adelaide Greco and Donatella Montanaro and Arturo Brunetti and Lucio Pastore",
year = "2013",
doi = "10.2174/1566523211313030005",
language = "English",
volume = "13",
pages = "202--210",
journal = "Current Gene Therapy",
issn = "1566-5232",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - Thymidine kinase-mediated shut down of bone morphogenetic protein-4 expression allows regulated bone production

AU - Lombardo, Barbara

AU - Rocco, Teresa

AU - Esposito, Maria T.

AU - Cantilena, Bruno

AU - Gargiulo, Sara

AU - Greco, Adelaide

AU - Montanaro, Donatella

AU - Brunetti, Arturo

AU - Pastore, Lucio

PY - 2013

Y1 - 2013

N2 - Bone morphogenetic Proteins (BMPs) are growth factors also involved in ossification and chondrogenesis that have generated interest for their efficiency in inducing bone neo-synthesis. BMPs expression in engineered cells has been successful in stimulating osteoblastic differentiation and ectopic and orthotopic bone formation in vivo. We have previously shown that an adenoviral vector expressing bone morphogenetic protein type-4 (BMP-4) is able to efficiently drive bone formation in a rabbit model of discontinuous bone lesions. However, unregulated secretion of BMPs has also been implicated in bone overproduction and exostosis. We have constructed a replication-defective first generation adenoviral (FG-Ad) vector containing a cassette for the expression of BMP-4 associated with the Herpes Simplex virus thymidine kinase (TK) gene (FG-B4TK) in order to shut down BMP-4 expression and, therefore, regulate bone production. TK expression does not interfere with BMP-4 ability to induce ectopic bone formation in athymic nude mice. Administration of ganciclovir blocks ectopic bone production in quadriceps muscle transduced with the FG-B4TK with no effect on the contralateral muscle transduced with a vector expressing only BMP-4. Histological findings confirmed the pro-apoptotic activity of TK and the reduction of mineralized areas in the quadriceps transduced with FG-B4TK in mice treated with ganciclovir. We have generated a system to block BMP-4 secretion by inducing apoptosis in transduced cells therefore blocking unwanted bone formation. This system is an additional tool to generate regulated amount of bone in discontinuous bone lesions and can be easily coupled with biomaterials capable of recruiting cells and generating a local bioreactor.

AB - Bone morphogenetic Proteins (BMPs) are growth factors also involved in ossification and chondrogenesis that have generated interest for their efficiency in inducing bone neo-synthesis. BMPs expression in engineered cells has been successful in stimulating osteoblastic differentiation and ectopic and orthotopic bone formation in vivo. We have previously shown that an adenoviral vector expressing bone morphogenetic protein type-4 (BMP-4) is able to efficiently drive bone formation in a rabbit model of discontinuous bone lesions. However, unregulated secretion of BMPs has also been implicated in bone overproduction and exostosis. We have constructed a replication-defective first generation adenoviral (FG-Ad) vector containing a cassette for the expression of BMP-4 associated with the Herpes Simplex virus thymidine kinase (TK) gene (FG-B4TK) in order to shut down BMP-4 expression and, therefore, regulate bone production. TK expression does not interfere with BMP-4 ability to induce ectopic bone formation in athymic nude mice. Administration of ganciclovir blocks ectopic bone production in quadriceps muscle transduced with the FG-B4TK with no effect on the contralateral muscle transduced with a vector expressing only BMP-4. Histological findings confirmed the pro-apoptotic activity of TK and the reduction of mineralized areas in the quadriceps transduced with FG-B4TK in mice treated with ganciclovir. We have generated a system to block BMP-4 secretion by inducing apoptosis in transduced cells therefore blocking unwanted bone formation. This system is an additional tool to generate regulated amount of bone in discontinuous bone lesions and can be easily coupled with biomaterials capable of recruiting cells and generating a local bioreactor.

KW - Bone production regulation

KW - Fg-B4

KW - Fg-B4TK

UR - http://www.scopus.com/inward/record.url?scp=84878661287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878661287&partnerID=8YFLogxK

U2 - 10.2174/1566523211313030005

DO - 10.2174/1566523211313030005

M3 - Article

VL - 13

SP - 202

EP - 210

JO - Current Gene Therapy

JF - Current Gene Therapy

SN - 1566-5232

IS - 3

ER -